Table 4.
AUC and its 95% CI for each body index according to MetS components
| High BP | Dysglycemia | Low HDL-C | High TG | MetS | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| AUC | 95% CI | AUC | 95% CI | AUC | 95% CI | AUC | 95% CI | AUC | 95% CI | |
| Male | ||||||||||
| WHtR | 0.602* | 0.574–0.630 | 0.669* | 0.641–0.695 | 0.579* | 0.543–0.616 | 0.633* | 0.605–0.660 | 0.739* | 0.691–0.787 |
| BRI | 0.602* | 0.574–0.630 | 0.669* | 0.641–0.695 | 0.579* | 0.543–0.616 | 0.633* | 0.605–0.660 | 0.739* | 0.691–0.787 |
| WWI | 0.581* | 0.552–0.609 | 0.655* | 0.627–0.682 | 0.563* | 0.527–0.599 | 0.598* | 0.565–0.632 | 0.689* | 0.636–0.742 |
| AVI | 0.571* | 0.543–0.599 | 0.617* | 0.589–0.644 | 0.591* | 0.555–0.628 | 0.634* | 0.606–0.666 | 0.743* | 0.690–0.796 |
| ABSI | 0.540# | 0.512–0.569 | 0.608* | 0.580–0.665 | 0.561# | 0.525–0.598 | 0.579* | 0.550–0.607 | 0.663* | 0.606–0.719 |
| Female | ||||||||||
| WHtR | 0.688* | 0.666–0.710 | 0.713* | 0.691–0.734 | 0.605* | 0.581–0.628 | 0.712* | 0.690–0.733 | 0.817* | 0.798–0.835 |
| BRI | 0.688* | 0.666–0.710 | 0.713* | 0.691–0.734 | 0.605* | 0.581–0.628 | 0.712* | 0.690–0.733 | 0.817* | 0.798–0.835 |
| WWI | 0.688* | 0.665–0.710 | 0.705* | 0.682–0.726 | 0.556* | 0.532–0.580 | 0.684* | 0.661–0.706 | 0.768* | 0.748–0.788 |
| AVI | 0.659* | 0.636–0.682 | 0.692* | 0.669–0.713 | 0.614* | 0.590–0.637 | 0.690* | 0.667–0.712 | 0.819* | 0.800–0.837 |
| ABSI | 0.660* | 0.637–0.682 | 0.682* | 0.660–0.704 | 0.541^ | 0.484–0.598 | 0.647* | 0.623–0.669 | 0.744* | 0.723–0.765 |
Bold indicates the maximum
WtHR waist-to-height ratio, BRI body roundness index, WWI weight adjusted waist index, AVI abdominal volume index, ABSI a body shape index, BP blood pressure, TG triglyceride, HDL-C HDL cholesterol, MetS metabolic syndrome
*p < 0.001; #p < 0.05; ^p > 0.05